July 2024
1. WICHMANN CW, Morgan KA, Cao Z, Osellame LD, et al
   Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of (225)Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.
   J Nucl Med. 2024 Jul 25:jnumed.123.266894. doi: 10.2967/jnumed.123.266894.
   

   >> Share

   
   June 2024
2. COMBET-CURT V, Buchalet C, Malicot KL, Lemanski C, et al
   Prognostic Value of (18)F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE.
   J Nucl Med. 2024 Jun 27:jnumed.124.267626. doi: 10.2967/jnumed.124.267626.
   

   >> Share

   
   February 2024
3. TIKUM AF, Ketchemen JP, Doroudi A, Nambisan AK, et al
   Effectiveness of (225)Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models.
   J Nucl Med. 2024 Feb 15:jnumed.123.266204. doi: 10.2967/jnumed.123.266204.
   

   >> Share

   
   October 2023
4. LI X, Ye J, Wang J, Quan Z, et al
   First-in-Humans PET Imaging of KRAS(G12C) Mutation Status in Non-Small Cell Lung and Colorectal Cancer Patients Using [(18)F]PFPMD.
   J Nucl Med. 2023 Oct 12:jnumed.123.265715. doi: 10.2967/jnumed.123.265715.
   

   >> Share

   
   December 2022
5. MINNIX M, Kujawski M, Poku E, Yazaki PJ, et al
   Improved Tumor Responses with Sequential Targeted alpha-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice.
   J Nucl Med. 2022;63:1859-1864.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share